We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type |
---|---|---|---|
Trevena Inc | NASDAQ:TRVN | NASDAQ | Common Stock |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.0031 | 0.76% | 0.4126 | 0.3804 | 2.30 | 0.4352 | 0.38 | 0.4352 | 76,312 | 05:00:04 |
Presentation Details | |
Date: | Friday, February 26, 2021 |
Time: | 8:40 a.m. Eastern Time |
Presenter: | Bob Yoder, Senior Vice President and Chief Commercial Officer |
Webcast: | https://wsw.com/webcast/svbleerink47/trvn/2707456 |
A link to the webcast will be available on the Events page of the Investors section on the Company’s website at www.trevena.com/investors/events-presentations/ir-calendar.
About Trevena
Trevena, Inc. is a biopharmaceutical company focused on the development and commercialization of novel medicines for patients with CNS disorders. The Company has one approved product in the U.S., OLINVYK™ (oliceridine) injection, indicated in adults for the management of acute pain severe enough to require an intravenous opioid analgesic and for whom alternative treatments are inadequate. The Company also has four novel and differentiated investigational drug candidates: TRV250 for the acute treatment of migraine, TRV734 for maintenance treatment of opioid use disorder, and TRV027 for acute lung injury / abnormal blood clotting in COVID-19 patients. The Company has also identified TRV045, a novel S1P receptor modulator that may offer a new, non-opioid approach to treating a variety of CNS disorders.
For more information, please visit www.Trevena.com.
Investor Contact:Daniel FerryLifeSci AdvisorsPhone: 617-430-7576Email: IR@trevena.com
Company Contact:Bob Yoder, SVP and Chief Commercial OfficerTrevena, Inc.Phone: 610-354-8840
1 Year Trevena Chart |
1 Month Trevena Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions